| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110;
Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO 63110; and
Howard Hughes Medical Institute, Rheumatology Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110
Multiple studies have demonstrated that the NK cell activating receptor NKG2D can function as a costimulatory receptor for both mouse and human CD8+ T cells. However, it has recently been suggested that stimulation through NKG2D is insufficient for costimulation of CD8+ T cells. To aid in the delineation of NKG2D function in CTL responses, we investigated whether stimulation of NKG2D by the natural ligand RAE1
was able to costimulate effector functions of a murine CTL line generated from DUC18 TCR transgenic mice. We found that NKG2D was able to costimulate DUC CTL responses and did so in a manner similar to CD28 costimulation. The T cells exhibited increased proliferation, IFN-
release, and cytotoxicity when presented antigenic peptide by P815 cells expressing RAE1 or B7-1 compared with untransfected P815. In addition, both RAE1 and B7-1 enhanced Ag-independent IFN- secretion in response to IL-12 and IL-18 by DUC CTL. However, only costimulation through CD28 allowed for DUC CTL survival upon secondary stimulation, whereas ligation of NKG2D, but not CD28, induced DUC CTL to form an immune synapse with target cells in the absence of TCR stimulation. Understanding the outcomes of these differences may allow for a better understanding of T cell costimulation in general.
This article has been cited by other articles:
|
|
 |
|
  C. B. Lai, Y. Zhang, S. L. Rogers, and D. L. Mager Creation of the two isoforms of rodent NKG2D was driven by a B1 retrotransposon insertion Nucleic Acids Res., May 1, 2009; 37(9): 3032 - 3043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Fujii, A. Goto, and K. Shimizu Antigen mRNA-transfected, allogeneic fibroblasts loaded with NKT-cell ligand confer antitumor immunity Blood, April 30, 2009; 113(18): 4262 - 4272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Whang, N. Guerra, and D. H. Raulet Costimulation of Dendritic Epidermal {gamma}{delta} T Cells by a New NKG2D Ligand Expressed Specifically in the Skin J. Immunol., April 15, 2009; 182(8): 4557 - 4564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cerboni, M. Ardolino, A. Santoni, and A. Zingoni Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells Blood, March 26, 2009; 113(13): 2955 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Markiewicz, E. L. Wise, Z. S. Buchwald, E. E. Cheney, T. H. Hansen, A. Suri, S. Cemerski, P. M. Allen, and A. S. Shaw IL-12 Enhances CTL Synapse Formation and Induces Self-Reactivity J. Immunol., February 1, 2009; 182(3): 1351 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Beal, N. Anikeeva, R. Varma, T. O. Cameron, P. J. Norris, M. L. Dustin, and Y. Sykulev Protein Kinase C{theta} Regulates Stability of the Peripheral Adhesion Ring Junction and Contributes to the Sensitivity of Target Cell Lysis by CTL J. Immunol., October 1, 2008; 181(7): 4815 - 4824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cao, X. Xi, Z. Wang, L. Dong, Z. Hao, L. Cui, C. Ma, and W. He Four novel ULBP splice variants are ligands for human NKG2D Int. Immunol., August 1, 2008; 20(8): 981 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS J. Leukoc. Biol., July 1, 2008; 84(1): 1 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Walsh, L. L. Lanier, and T. E. Lane NKG2D Receptor Signaling Enhances Cytolytic Activity by Virus-Specific CD8+ T Cells: Evidence for a Protective Role in Virus-Induced Encephalitis J. Virol., March 15, 2008; 82(6): 3031 - 3044. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Giurisato, M. Cella, T. Takai, T. Kurosaki, Y. Feng, G. D. Longmore, M. Colonna, and A. S. Shaw Phosphatidylinositol 3-Kinase Activation Is Required To Form the NKG2D Immunological Synapse Mol. Cell. Biol., December 15, 2007; 27(24): 8583 - 8599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Choi, Y. H. Kim, W. J. Kang, S. K. Lee, K. H. Kim, S. M. Shin, W. M. Yokoyama, T. Y. Kim, and B. S. Kwon Mechanisms Involved in Synergistic Anticancer Immunity of Anti-4-1BB and Anti-CD4 Therapy Cancer Res., September 15, 2007; 67(18): 8891 - 8899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cao, X. Xi, Z. Hao, W. Li, Y. Kong, L. Cui, C. Ma, D. Ba, and W. He RAET1E2, a Soluble Isoform of the UL16-binding Protein RAET1E Produced by Tumor Cells, Inhibits NKG2D-mediated NK Cytotoxicity J. Biol. Chem., June 29, 2007; 282(26): 18922 - 18928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Barber, T. Zhang, L. R. DeMars, J. Conejo-Garcia, K. F. Roby, and C. L. Sentman Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer Cancer Res., May 15, 2007; 67(10): 5003 - 5008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Chen, P. P. Trivedi, B. Ge, K. Krzewski, and J. L. Strominger Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity PNAS, April 10, 2007; 104(15): 6329 - 6334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Roda-Navarro, M. Vales-Gomez, S. E. Chisholm, and H. T. Reyburn Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function PNAS, July 25, 2006; 103(30): 11258 - 11263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Bui, L. N. Carayannopoulos, L. L. Lanier, W. M. Yokoyama, and R. D. Schreiber IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors J. Immunol., January 15, 2006; 176(2): 905 - 913. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
